Eli Lilly stock rises after hours on Nimbus obesity pill deal as Ventyx talks surface
New York, January 6, 2026, 18:18 EST — After-hours Eli Lilly and Company stock closed up 2.2% on Tuesday and was up about 0.1% in after-hours trading after Nimbus Therapeutics said it struck a research and licensing deal with the drugmaker to pursue an oral obesity treatment. Yahoo Finance The news lands as investors look for the next leg of…